Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Equity Ratio (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Equity Ratio data on record, last reported at 0.92 in Q3 2021.

  • For Q3 2021, Equity Ratio rose 677.64% year-over-year to 0.92; the TTM value through Sep 2021 reached 0.92, up 677.64%, while the annual FY2020 figure was 0.94, 45.53% up from the prior year.
  • Equity Ratio reached 0.92 in Q3 2021 per COGT's latest filing, down from 0.93 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.95 in Q1 2021 and bottomed at 1.41 in Q1 2018.
  • Average Equity Ratio over 4 years is 0.53, with a median of 0.66 recorded in 2020.
  • Peak YoY movement for Equity Ratio: tumbled 132.06% in 2020, then surged 677.64% in 2021.
  • A 4-year view of Equity Ratio shows it stood at 0.7 in 2018, then fell by 8.32% to 0.64 in 2019, then skyrocketed by 45.53% to 0.94 in 2020, then decreased by 2.08% to 0.92 in 2021.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.92 in Q3 2021, 0.93 in Q2 2021, and 0.95 in Q1 2021.